COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > With the merger at the bottom of the biotech bear...

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Aug 23, 2024 10:10am

68 Views

Post# 36193247

With the merger at the bottom of the biotech bear...

With the merger at the bottom of the worst biotech bear market in history after a 40 year high in inflation and the sharpest interest rate hike in modern history and with CSCI's new website "coming soon" and a fulsome update expected shortly and with a string of key events anticipated...

@carlquintanilla